Invictus Md Strategies Corp.

Invictus MD Strategies Corp. (OTC: IVITF) (CSE: IMH.CN), Cannabis Sativa Inc. (OTC: CBDS), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Insys Therapeutics Inc. (NASDAQ: INSY), Cara Therapeutics Inc. (NASDAQ: CARA) The report also indicated the factors that drive the growth: “Rapid legalizing and growing awareness about the medicinal properties of marijuana to boost the market over the forecasted period Among the country markets in North America, The U.S. and Canada accumulate significant revenue, owing to rapid legalization in the country, increasing number of evidences in favor of marijuana possessing medicinal properties, and growing acceptance among end-users” Invictus MD Strategies Corp. (OTC: IVITF) (CSE: IMH.CN) just announced today that, “on February 6, 2017 it had entered into a binding letter of intent (“LOI”) for an option to acquire 100% (the “Option”) of the outstanding shares of a Late Stage Applicant (the “OptionCo”) under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) marijuana business from its current shareholders (the “Vendors”). In early January 2017, OptionCo had its Pre-license inspection from Health Canada and expects to receive a license to cultivate under the ACMPR in short order. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres (the “Property”), which is expected to have production capacity of up to 6,000 kg per annum.

To read more visit

Posted in: investing, News, stocks

Comments are closed.